Date | Time | Source | Headline | Symbol | Company |
12/10/2013 | 07:46 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
12/10/2013 | 07:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:43 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:42 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:39 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:36 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:35 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:19 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:17 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:14 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:13 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/10/2013 | 06:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/10/2013 | 22:58 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/10/2013 | 20:34 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/10/2013 | 20:21 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/10/2013 | 20:00 | PR Newswire (US) | Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |